Paskett Electra D, Naughton Michelle J, McCoy Thomas P, Case L Douglas, Abbott Jill M
Ohio State University Comprehensive Cancer Center, A356 Starling-Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82. doi: 10.1158/1055-9965.EPI-06-0168.
Breast cancer survivors suffer from lymphedema of the arm and/or hand. Accurate estimates of the incidence and prevalence of lymphedema are lacking, as are the effects of this condition on overall quality of life.
Six hundred twenty-two breast cancer survivors (age, <or=45 years at diagnosis) were followed with semiannual questionnaires for 36 months after surgery to determine the incidence of lymphedema, prevalence of persistent swelling, factors associated with each, and quality of life.
Of those contacted and eligible for the study, 93% agreed to participate. Fifty-four percent reported arm or hand swelling by 36 months after surgery, with 32% reporting persistent swelling. Swelling was reported to occur in the upper arm (43%), the hand only (34%), and both arm and hand (22%). Factors associated with an increased risk of developing swelling included having a greater number of lymph nodes removed [hazards ratio (HR), 1.02; P < 0.01], receiving chemotherapy (HR, 1.76; P = 0.02), being obese (HR, 1.51 versus normal weight; P = 0.01), and being married (HR, 1.36; P = 0.05). Factors associated with persistent swelling were having more lymph nodes removed (odds ratio, 1.03; P = 0.01) and being obese (odds ratio, 2.24 versus normal weight; P < 0.01). Women reporting swelling had significantly lower quality of life as measured by the functional assessment of cancer therapy-breast total score and the SF-12 physical and mental health subscales (P < 0.01 for each).
Lymphedema occurs among a substantial proportion of young breast cancer survivors. Weight management may be a potential intervention for those at greatest risk of lymphedema to maintain optimal health-related quality of life among survivors.
乳腺癌幸存者会遭受手臂和/或手部的淋巴水肿。目前缺乏对淋巴水肿发病率和患病率的准确估计,也不清楚这种病症对总体生活质量的影响。
对622名乳腺癌幸存者(诊断时年龄≤45岁)在术后36个月内每半年进行问卷调查,以确定淋巴水肿的发病率、持续性肿胀的患病率、与之相关的因素以及生活质量。
在被联系且符合研究条件的人群中,93%同意参与。54%的人在术后36个月报告有手臂或手部肿胀,其中32%报告有持续性肿胀。据报告,肿胀发生在上臂的占43%,仅手部的占34%,手臂和手部都有的占22%。与发生肿胀风险增加相关的因素包括切除的淋巴结数量较多[风险比(HR),1.02;P<0.01]、接受化疗(HR,1.76;P = 0.02)、肥胖(HR,与正常体重相比为1.51;P = 0.01)以及已婚(HR,1.36;P = 0.05)。与持续性肿胀相关的因素是切除的淋巴结较多(优势比,1.03;P = 0.01)和肥胖(优势比,与正常体重相比为2.24;P<0.01)。报告有肿胀的女性,通过癌症治疗功能评估-乳腺总分以及SF-12身心健康子量表测量,其生活质量显著较低(每项P<0.01)。
相当一部分年轻乳腺癌幸存者会出现淋巴水肿。体重管理可能是对淋巴水肿风险最高的人群的一种潜在干预措施,以在幸存者中维持最佳的健康相关生活质量。